Leviashvili B I
Klin Med (Mosk). 1989 Mar;67(3):34-7.
Examination included 70 patients with diabetes mellitus in combination with arterial hypertension of different origin (II stage essential hypertension and symptomatic renal arterial hypertension). Crystepin (2-3 tablets per 24 h) in combination with beta-adrenoblocker obsidan (40-80 mg/24 h) was used for treatment. Basic hemodynamic parameters and the state of the renin-aldosterone system were determined. The hemodynamic hypotensive effects in these patients due to the influence of the above therapy are uniform and depend on the form of attendant arterial hypertension. The hypotensive effect of crystepin used in combination with obsidan was more pronounced in patients with diabetes and II stage essential hypertension than that in those with diabetes and renal hypertension. The concentration of aldosterone and renin activity of blood plasma in patients with diabetes and arterial hypertension during treatment with crystepin and obsidan had no regular connection with the hemodynamic parameters.
研究纳入了70例患有糖尿病合并不同类型动脉高血压(II期原发性高血压和症状性肾动脉高血压)的患者。采用克立斯平(每24小时2 - 3片)联合β - 肾上腺素能阻滞剂奥昔坦(40 - 80毫克/24小时)进行治疗。测定了基本血流动力学参数和肾素 - 醛固酮系统的状态。上述治疗对这些患者的血流动力学降压作用是一致的,且取决于伴随的动脉高血压类型。与糖尿病合并肾性高血压患者相比,克立斯平联合奥昔坦对糖尿病合并II期原发性高血压患者的降压作用更为显著。在使用克立斯平和奥昔坦治疗期间,糖尿病合并动脉高血压患者血浆醛固酮浓度和肾素活性与血流动力学参数无规律关联。